Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2010

View Archived Issues

New Pim kinase inhibitor ARRY-770 reduces airway hyperresponsiveness in mice

Adalimumab improves quality of life in Crohn's disease patients

Evotec Neurosciences claims bradykinin B1 receptor antagonists

CETP gene polymorphism linked to reduced risk for dementia

Topical WBI-1001 improves atopic dermatitis in double-blind trial

Roche discovers new GlyT-1 inhibitors

Merck KGaA discloses novel tyrosine kinase inhibitors

Bayer Schering claims new adenosine A1 receptor antagonists

Sanofi-aventis patents new cannabinoid CB1 receptor antagonists

NIAID awards PDS phase II grant for HPV cancer vaccine

Ark withdraws Cerepro MAA after EMA's request for further trial in malignant glioma

Vernalis terminates agreement with PCH and regains rights to frovatriptan

Biotie and Pfizer to end discovery phase of development of PDE10 inhibitors for schizophrenia

Stanford University requests data from Favrille's cancer vaccine trials

Ischemix begins phase IIa CMX-2043 trial in ischemia reperfusion injury

Ista receives action date for FDA review of XiDay sNDA

Chimerix begins phase II CMX-001 study in CMV-seropositive stem cell transplant recipients

Bristol-Myers and AstraZeneca begin phase IV Onglyza trial

Enrollment begins in phase IIb trial of NTx-265 in acute ischemic stroke

mtm laboratories launches cervical cancer test CINtec Plus in Europe

Omthera to advance Epanova for hypertriglyceridemia

Celltrion develops broad-spectrum human monoclonal antibodies against influenza

Omeros licenses Asubio's PDE7 inhibitors for movement disorders

Harvard and Dana-Farber grant Acetylon exclusive license to HDAC inhibitor discovery platform

Abbott and GSK to develop molecular diagnostic test for skin cancer treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...